Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro

BACKGROUND: TLR4/MD-2 complex-mediated MyD88-dependent activation of NF-κB and Akt promotes tumor-associated immunosuppression in epithelial ovarian cancer (EOC) via induction of immunesuppressive cytokines and indoleamine 2,3-dioxygenase (IDO). Atractylenolide I (AO-1) is a naturally occurring sesq...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hong, Zhang, Guonan, Huang, Jianming, Ma, Shiqi, Mi, Kun, Cheng, Jia, Zhu, Yi, Zha, Xiao, Huang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847224/
https://www.ncbi.nlm.nih.gov/pubmed/27118139
http://dx.doi.org/10.1186/s12967-016-0845-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847224/
https://www.ncbi.nlm.nih.gov/pubmed/27118139
http://dx.doi.org/10.1186/s12967-016-0845-5

Ejemplares similares